111 related articles for article (PubMed ID: 25867708)
1. High-throughput screening for chemical modulators of post-transcriptionally regulated genes.
Sidarovich V; Adami V; Quattrone A
J Vis Exp; 2015 Mar; (97):. PubMed ID: 25867708
[TBL] [Abstract][Full Text] [Related]
2. A cell-based high-throughput screen addressing 3'UTR-dependent regulation of the MYCN gene.
Sidarovich V; Adami V; Quattrone A
Mol Biotechnol; 2014 Jul; 56(7):631-43. PubMed ID: 24515800
[TBL] [Abstract][Full Text] [Related]
3. A possible role of IL-1ra 3'-untranslated region in modulation of protein production.
Yamshchikov VF; Mishina M; Cominelli F
Cytokine; 2002 Jan; 17(2):98-107. PubMed ID: 11886177
[TBL] [Abstract][Full Text] [Related]
4. MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.
Haug BH; Henriksen JR; Buechner J; Geerts D; Tømte E; Kogner P; Martinsson T; Flægstad T; Sveinbjørnsson B; Einvik C
Carcinogenesis; 2011 Jul; 32(7):1005-12. PubMed ID: 21572098
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a novel neuroprotective compound, AS1219164, by high-throughput chemical screening of a newly identified apoptotic gene marker.
Yamazaki T; Muramoto M; Okitsu O; Morikawa N; Kita Y
Eur J Pharmacol; 2011 Nov; 669(1-3):7-14. PubMed ID: 21824470
[TBL] [Abstract][Full Text] [Related]
6. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.
Rapisarda A; Uranchimeg B; Scudiero DA; Selby M; Sausville EA; Shoemaker RH; Melillo G
Cancer Res; 2002 Aug; 62(15):4316-24. PubMed ID: 12154035
[TBL] [Abstract][Full Text] [Related]
7. A mammalian cell-based assay for screening inhibitors of RNA cleavage.
Yen L; Stockwell BR; Mulligan RC
Methods Mol Biol; 2009; 540():335-47. PubMed ID: 19381571
[TBL] [Abstract][Full Text] [Related]
8. A cell-based high-throughput screening assay for posttranscriptional utrophin upregulation.
Moorwood C; Soni N; Patel G; Wilton SD; Khurana TS
J Biomol Screen; 2013 Apr; 18(4):400-6. PubMed ID: 23112083
[TBL] [Abstract][Full Text] [Related]
9. Endogenous Locus Reporter Assays.
Liu Y; Hermes J; Li J; Tudor M
Methods Mol Biol; 2018; 1755():163-177. PubMed ID: 29671270
[TBL] [Abstract][Full Text] [Related]
10. Posttranscriptional regulation of acute phase serum amyloid A2 expression by the 5'- and 3'-untranslated regions of its mRNA.
Longley DB; Steel DM; Whitehead AS
J Immunol; 1999 Oct; 163(8):4537-45. PubMed ID: 10510397
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of novel small molecule disruptors of HuR-mRNA interaction.
Wu X; Lan L; Wilson DM; Marquez RT; Tsao WC; Gao P; Roy A; Turner BA; McDonald P; Tunge JA; Rogers SA; Dixon DA; Aubé J; Xu L
ACS Chem Biol; 2015 Jun; 10(6):1476-84. PubMed ID: 25750985
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Post-transcriptional Gene Regulation of Nod-Like Receptors via the 3'UTR.
Haneklaus M
Methods Mol Biol; 2016; 1390():197-211. PubMed ID: 26803631
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma.
Muth D; Ghazaryan S; Eckerle I; Beckett E; Pöhler C; Batzler J; Beisel C; Gogolin S; Fischer M; Henrich KO; Ehemann V; Gillespie P; Schwab M; Westermann F
Cancer Res; 2010 May; 70(9):3791-802. PubMed ID: 20424123
[TBL] [Abstract][Full Text] [Related]
14. Expression of NLRR3 orphan receptor gene is negatively regulated by MYCN and Miz-1, and its downregulation is associated with unfavorable outcome in neuroblastoma.
Akter J; Takatori A; Hossain MS; Ozaki T; Nakazawa A; Ohira M; Suenaga Y; Nakagawara A
Clin Cancer Res; 2011 Nov; 17(21):6681-92. PubMed ID: 21908575
[TBL] [Abstract][Full Text] [Related]
15. Post-transcriptional regulation of the human inducible nitric oxide synthase (iNOS) expression by the cytosolic poly(A)-binding protein (PABP).
Casper I; Nowag S; Koch K; Hubrich T; Bollmann F; Henke J; Schmitz K; Kleinert H; Pautz A
Nitric Oxide; 2013 Sep; 33():6-17. PubMed ID: 23711718
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel pathways and molecules able to down-regulate PHOX2B gene expression by in vitro drug screening approaches in neuroblastoma cells.
Di Zanni E; Fornasari D; Ravazzolo R; Ceccherini I; Bachetti T
Exp Cell Res; 2015 Aug; 336(1):43-57. PubMed ID: 25882494
[TBL] [Abstract][Full Text] [Related]
17. TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma.
Selmi A; de Saint-Jean M; Jallas AC; Garin E; Hogarty MD; Bénard J; Puisieux A; Marabelle A; Valsesia-Wittmann S
Cancer Lett; 2015 Feb; 357(1):412-418. PubMed ID: 25475555
[TBL] [Abstract][Full Text] [Related]
18. Mining the GEMS--a novel platform technology targeting post-transcriptional control mechanisms.
Bhattacharyya A; Trotta CR; Peltz SW
Drug Discov Today; 2007 Jul; 12(13-14):553-60. PubMed ID: 17631250
[TBL] [Abstract][Full Text] [Related]
19. Cis-acting elements in its 3' UTR mediate post-transcriptional regulation of KRAS.
Kim M; Kogan N; Slack FJ
Oncotarget; 2016 Mar; 7(11):11770-84. PubMed ID: 26930719
[TBL] [Abstract][Full Text] [Related]
20. Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastoma.
Schramm A; Köster J; Marschall T; Martin M; Schwermer M; Fielitz K; Büchel G; Barann M; Esser D; Rosenstiel P; Rahmann S; Eggert A; Schulte JH
Int J Cancer; 2013 Feb; 132(3):E106-15. PubMed ID: 22907398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
